Closed-loop insulin delivery: update on the state of the field and emerging technologies.

Published in: Expert review of medical devices (2022)

Commercial hybrid closed-loop insulin delivery systems are efficacious, consistently improving glycemic control when compared to standard therapy. Challenges remain in widespread adoption due to clinical inertia and the lack of resources to embrace technological developments by health care professionals.

Keyphrases

glycemic control
type diabetes
healthcare
blood glucose
weight loss
insulin resistance
stem cells
metabolic syndrome
mesenchymal stem cells